INmune Bio Inc. Common stock (NASDAQ: INMB) last traded at $2.32, up 7.41% on the session. The quote above updates while this page is open; the figures below are drawn from INmune Bio Inc. Common stock’s own filings and are restated only when a new one is published.
INmune Bio Inc. Common stock trades on NASDAQ under the ticker INMB. Its market capitalisation is $64.39 million.
Valuation measures for INmune Bio Inc. Common stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $64.39M |
|---|---|
| Enterprise value | $46.12M |
| Price / sales | 1287.78 |
| Price / book | 3.16 |
| Beta | 2.54 |
Trailing-twelve-month figures tagged in INmune Bio Inc. Common stock's XBRL filings with the SEC.
| Revenue (TTM) | $50.0K |
|---|---|
| Net income (TTM) | -$18.42M |
| EPS (TTM) | -$0.630 |
| Operating margin | -40390.00% |
| Return on equity | -90.44% |
| Cash | $24.75M |
Range and volume for INMB over the past 52 weeks.
| 52-week high | $2.44 |
|---|---|
| 52-week low | $1.09 |
| Volume | 519.6K |
| Average volume | 719.1K |
| Previous close | $2.16 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.